• Contrast
    • Layout
    • Font

The next GCCTI workshop will be held on Friday 1 October 2021, virtually.

Scientific Steering Group

The GCCTI is supported by a national Scientific Steering Group which includes representation from individuals with scientific, clinical and methodological expertise to inform the direction of the initiative.

Professor Martin Stockler
Oncology Co-Director, NHMRC CTC

Professor Steve Ackland
Director – Hunter Cancer Research Alliance

Dr Fiona Hegi
Radiation Oncologist and Senior Lecturer (University of Newcastle)

Dr Kate Mahon
Medical Oncologist (Chris O’Brien Lifehouse)

Professor Anna DeFazio
Sydney West Chair of Translational Cancer Research, Centre of Cancer Research
(The University of Sydney)

Dr Alex Dobrovic
Translational Genomics & Epigenomics Laboratory (Olivia Newton-John Cancer Research Institute)

Dr Paul Jackson
Manager, Research and Clinical Trials (Cancer Australia)

A/Professor Clare Scott
Medical Oncologist and Laboratory Head, Stem Cells and Cancer Division (Walter and Eliza Hall Institute)

John Stubbs

Professor Rosalie Viney
Director, CHERE (University of Technology Sydney)

Professor Paul Waring
Head of Pathology (University of Melbourne)

Dr Jayesh Desai
Medical Oncologist (Peter MacCallum Cancer Centre)

Dr William Stevenson
Clinical Haematologist (Royal North Shore Hospital)

Craig Gedye
Calvary Mater Newscastle


Working Groups

Expert working groups will be established for new concepts selected for development into proposals. The working groups will be formed on as needed basis, and will draw members from the project team, SSG, Advisory Panel and other experts as required (such as quality of life and/or health and pharmaco-economic expertise). The working groups will provide content knowledge, expertise and input required to develop high quality proposals for grant submissions.